CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 18 enrolled
Drug / intervention
intravenous nitroglycerindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02265965
NCT02265965Phase 4Completed
CompareCT.gov

Randomized Controlled Trial of IV Nitroglycerin in Cesarean Deliveries After Second Stage Arrest for the Prevention of Uterine Extension

University of California, San Francisco·interventional·Posted Oct 16, 2014·Updated May 19, 2020

In Brief

A Phase 4 clinical trial evaluating intravenous nitroglycerin for Prolonged Second Stage of Labor. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProlonged Second Stage of Labor
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 16, 2014
Enrollment StartOct 1, 2015
Primary CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.7 years ago

Interventions

intravenous nitroglycerindrug

Infusion at started at time of hysterotomy and stopped at neonate delivery